Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
Company announcement No. 31 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
EAST RUTHERFORD, N.J., July 7, 2026 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the…
Broker's Call: Mankind Pharma (Add)
After years of growth led by distribution reach and prescription volume, Mankind Pharma is re-orienting towards research-led, niche and specialty therapies where competition is thinner. A calculated move into low-competition specialty niches is a…
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
MUMBAI, India, July 7, 2026 /CNW/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global…
NCLT approves Torrent Pharma-JB Chemicals merger
The National Company Law Tribunal (NCLT) has approved the merger of JB Chemicals & Pharmaceuticals Ltd with Torrent Pharmaceuticals Ltd, clearing a key regulatory hurdle for one of the largest consolidation deals in India's pharmaceutical sector.
Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
PRESS RELEASE, July 07, 2026 – 08:00 CDT Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics ITASCA, IL, US and HUNTSVILLE, AL, US – July 07, 2026. Today, Biocartis, an…
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada
Based on regulatory agency feedback, the Company plans a registrational study that will evaluate hospitalization as the primary outcome measure, supported by multiple functional assessments as secondary outcome measures. LONDON, July 6, 2026 /CNW/…
Jim Cramer says these are the 5 stocks to buy during this market rotation
CNBC's Jim Cramer said investors should use the latest market rotation as an opportunity to buy high-quality companies that were swept lower by broad institutional selling. He highlighted Johnson & Johnson, PepsiCo, Starbucks, Constellation Brands…
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock's Asembia Buy
News The Cigna Group's Evenorth health services business has committed $100 million to support a new artificial intelligence-powered pharmacy program and a private equity firm's purchase of Asembia are only the latest in a wave of huge investments…
IDEXX Laboratories Does Not Need More Vet Visits--But It Needs More Tests Per Visit (NASDAQ:IDXX)
IDEXX Laboratories (IDXX) is rated Hold, as its premium valuation (~38x 2026E EPS) already assumes strong recurring revenue and diagnostics growth. IDXX is growing diagnostics revenue despite declining veterinary visits, leveraging inVue Dx and…
Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS)
Alpha Tau Medical (DRTS) pioneers alpha emitter-based targeted radiation therapy, aiming for highly localized tumor destruction with minimal systemic toxicity. DRTS's Alpha DaRT platform is advancing in recurrent cutaneous squamous cell carcinoma…
Apollo economist warns AI profit gains outside tech could take 'well beyond' what Wall Street expects
Outside tech, there's no sign AI is boosting profit margins, writes Torsten Slok, chief economist at US financial firm Apollo. AI company valuations rest entirely on the promise of rising margins at S&P 493 companies (the index minus 'the…
Stronger than Ozempic. Not exactly legal. 'Reta' has entered the chat.
Last summer, the musician Angel Money wanted to lose weight ahead of a music video shoot. A friend of hers had been injecting herself with a peptide called retatrutide. Money was curious. “She handed me a vial as a gift, basically, and was…
These are the best stocks in the worst sectors for investors betting on a rotation, says Josh Brown
(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — As of Friday's close, approximately 68% of S & P 500 components were trading above their own 200-day moving average.
Vertex Pharmaceuticals Stock Is Soaring and at a New All-Time High. Could It Still Be Heading Even Higher?
When a stock hits a 52-week high, that's a great sign the business is doing well. And when it hits a new all-time high, then you know the market is really excited about what's ahead for the business. But at the same time, there can also be concerns…
Receive a Daily briefing on Pharma Industry News
Get Started